Peck-Radosavljevic M - Search Results

1

Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.

Angermayr B, Luca A, König F, Bertolini G, Ploner M, Gridelli B, Ulbrich G, Reiberger T, Bosch J, Peck-Radosavljevic M. Angermayr B, et al. Eur J Clin Invest. 2009 Jan;39(1):65-71. doi: 10.1111/j.1365-2362.2008.02063.x. Eur J Clin Invest. 2009. PMID: 19087131

2

Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver?

Peck-Radosavljevic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Längle F, Steininger R, Mühlbacher F, Gangl A. Peck-Radosavljevic M, et al. J Hepatol. 1997 Jul;27(1):127-31. doi: 10.1016/s0168-8278(97)80291-7. J Hepatol. 1997. PMID: 9252085 Clinical Trial.

3

Direct evidence for an increase in thrombopoiesis after liver transplantation.

Stiegler G, Stohlawetz P, Peck-Radosavljevic M, Jilma B, Pidlich J, Wichlas M, Höcker P, Panzer S. Stiegler G, et al. Eur J Clin Invest. 1998 Sep;28(9):755-9. doi: 10.1046/j.1365-2362.1998.00348.x. Eur J Clin Invest. 1998. PMID: 9767375

4

Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome.

Cejna M, Peck-Radosavljevic M, Schoder M, Thurnher S, Ba-Ssalamah A, Angermayr B, Kaserer K, Pokrajac B, Lammer J. Cejna M, et al. J Vasc Interv Radiol. 2002 Feb;13(2 Pt 1):193-9. doi: 10.1016/s1051-0443(07)61938-1. J Vasc Interv Radiol. 2002. PMID: 11830626

5

ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.

Cejna M, Peck-Radosavljevic M, Thurnher S, Schoder M, Rand T, Angermayr B, Lammer J. Cejna M, et al. Cardiovasc Intervent Radiol. 2002 Sep-Oct;25(5):365-72. doi: 10.1007/s00270-001-0121-8. Epub 2002 Mar 23. Cardiovasc Intervent Radiol. 2002. PMID: 11981612

6

Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.

Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M. Angermayr B, et al. Gut. 2003 Jun;52(6):879-85. doi: 10.1136/gut.52.6.879. Gut. 2003. PMID: 12740346 Free PMC article.

7

Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents.

Angermayr B, Cejna M, Koenig F, Karnel F, Hackl F, Gangl A, Peck-Radosavljevic M; Vienna TIPS Study Group. Angermayr B, et al. Hepatology. 2003 Oct;38(4):1043-50. doi: 10.1053/jhep.2003.50423. Hepatology. 2003. PMID: 14512892

8

Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma.

Ferlitsch A, Kreil A, Bauer E, Schmidinger H, Schillinger M, Gangl A, Peck-Radosavljevic M. Ferlitsch A, et al. Eur J Clin Invest. 2004 Mar;34(3):218-23. doi: 10.1111/j.1365-2362.2004.01321.x. Eur J Clin Invest. 2004. PMID: 15025681

9

Transjugular intrahepatic portosystemic shunt in Vienna--a decade later.

Angermayr B, Cejna M, Karnel F, Gschwantler M, König F, Pidlich J, Mendel H, Brunner H, Pichler L, Ferenci P, Lammer J, Gangl A, Peck-Radosavljevic M. Angermayr B, et al. Wien Klin Wochenschr. 2004 Sep 30;116(17-18):608-13. doi: 10.1007/s00508-004-0207-9. Wien Klin Wochenschr. 2004. PMID: 15515878

10

Influence of clinical factors on the haemolysis marker haptoglobin.

Körmöczi GF, Säemann MD, Buchta C, Peck-Radosavljevic M, Mayr WR, Schwartz DW, Dunkler D, Spitzauer S, Panzer S. Körmöczi GF, et al. Eur J Clin Invest. 2006 Mar;36(3):202-9. doi: 10.1111/j.1365-2362.2006.01617.x. Eur J Clin Invest. 2006. PMID: 16506966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page